GalNAc Cluster Amide C7 Linker DMT Succinate LCAA CPG 1000Å
| Catalog No. | G1000-506-35 |
| Purity | 0 |
| Storage Condition | 2-8℃ |
GalNAc Cluster Amide C7 Linker DMT Succinate LCAA CPG 1000Å
GalNAc Cluster Amide C7 Linker DMT Succinate LCAA CPG 1000Å - N (Normal) is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Shipping notes
Shipping notes
Specifications
Specifications
-
Catalog No.G1000-506-35
-
SMILESO=C(COCCOCCOCCO[C@@H]1O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1NC(C)=O)NCCCC[C@@H](C(NCCCCC(COC(CCC(NC)=O)=O)COC(C2=CC=CC=C2)(C3=CC=C(OC)C=C3)C4=CC=C(OC)C=C4)=O)NC([C@H](CCCCNC(COCCOCCOCCO[C@@H]5O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@H]5NC(C)=O)=O)NC(COCCOCCOCCO[C@@H]6O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@H]6NC(C)=O)=O)=O
-
Purity0
-
Storage Condition2-8℃
Documentation
Documentation
-
Catalog No.G1000-506-35
-
SMILESO=C(COCCOCCOCCO[C@@H]1O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1NC(C)=O)NCCCC[C@@H](C(NCCCCC(COC(CCC(NC)=O)=O)COC(C2=CC=CC=C2)(C3=CC=C(OC)C=C3)C4=CC=C(OC)C=C4)=O)NC([C@H](CCCCNC(COCCOCCOCCO[C@@H]5O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@H]5NC(C)=O)=O)NC(COCCOCCOCCO[C@@H]6O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@H]6NC(C)=O)=O)=O
-
Purity0
-
Storage Condition2-8℃
Why choose Hongene?
Trusted Partner in Nucleic Acid
Enjoy enterprise‑grade quality even with small batch orders.
Integrated Supply & Commercial Scale
With nearly 30 years of expertise, we control a secure supply chain for RNA raw materials and provide reliable GMP-grade oligo synthesis from research to commercial kilogram-scale production.
Proprietary Technology & IP
Our proprietary Chemoenzymatic Ligation Platform combines chemical andenzymatic methods, enabling high-putity, cost-effective, and large-scale production of RNA-based therapeutics.
Rigorous Quality
We implement multiple stringent QC steps, maintain ISO certifications, and ensure >99% batch-to-batch consistency, reducing scale-up and PPQ risks.
Manufacturing Scalability
Hongene operates a 1.67-million-square-foot oligonucleotide manufacturing facility featuring advanced equipment, including multiple OligoPilot™ and OligoProcess™ synthesizers ranging from 10 to 1,800 mmol. Its 48 flexible production lines enable seamless, one-stop scale-up of API production from gram-level quantities to metric tons, achieving purity of ≥98% while supporting compliance with NMPA, FDA, and EMA regulatory requirements.
Global Business Network
Our products and services reach over 40 countries and regions, supporting around 3,000 clients worldwide.
